OWP
MRTX

Old Well Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Old Well Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,160
Closed -$205K – 53
2021
Q3 		$205K Buy
+1,160
New +$187K 0.11% 31
2021
Q2 		– Sell
-1,229
Closed -$211K – 50
2021
Q1 		$211K Buy
+1,229
New +$243K 0.1% 35

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Old Well Partners's MRTX Position: Q4 2021 in Review

Old Well Partners sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2021, closing a stake of 1,160 shares — an estimated $205K sold.

Old Well Partners first reported a position in MRTX in Q1 2021 and held it in 2 quarters. The position peaked at $211K in Q1 2021. 260 funds tracked by Wall St. Rank hold MRTX as of Q4 2021.

  • Old Well Partners reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Old Well Partners sold 1,160 Mirati Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $205K.
  • Old Well Partners first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Old Well Partners's Mirati Therapeutics, Inc. Common Stock position peaked at $211K in Q1 2021.
  • 260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Old Well Partners's 13F filing for Q4 2021, filed 14 Feb 2022.